Form 4: CareDx COO Keith Kennedy Reports Stock Transactions

CareDx's Chief Operating Officer, Keith Kennedy, reported the acquisition and disposal of company stock, including restricted stock units, in a recent SEC filing.

Summary

• Keith Kennedy, the Chief Operating Officer of CareDx, Inc., filed a Form 4 with the SEC.
• The filing reports changes in Mr. Kennedy's beneficial ownership of CareDx securities.
• On March 21, 2025, Mr. Kennedy acquired 77,195 shares of Common Stock in the form of restricted stock units.
• On March 21, 2025, Mr. Kennedy disposed of 77,195 shares of Common Stock.
• Following the reported transactions, Mr. Kennedy beneficially owns 147,296 shares of CareDx Common Stock.
• The restricted stock units vest over time, with one-third vesting on April 1, 2026, and the remaining two-thirds vesting in equal quarterly installments thereafter, subject to continuous employment.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing, indicating neutral sentiment. It reflects routine stock transactions by a company executive.

Positives

• The acquisition of restricted stock units aligns the executive's interests with the long-term performance of the company.

Future Outlook

The vesting schedule of the restricted stock units extends to the third anniversary of April 1, 2026, suggesting a long-term commitment from the executive.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Stakeholder Impact

• The filing provides transparency to shareholders regarding executive stock ownership.

Key Dates

Keywords

CareDx, CDNA, Keith Kennedy, Form 4, SEC Filing, Beneficial Ownership, Restricted Stock Units, Stock Transactions, Chief Operating Officer